Application of KANG FU PEN in Radical Concurrent Radiotherapy and Chemotherapy for Cervical Cancer to Prevent and Treat Radiation-induced Rectal Injury

• Status: Recruiting
• Trial end date: 2025-03-01

Summary

A total of 520 cases will be randomly divided into Kang Fu Pen (liquid dressing) enema intervention group (experimental group) and non-enema intervention group (control group), according to the ratio of 1:1.

• Phase: Phase 4

Details

• Lead Sponsor: Peking Union Medical College Hospital
• Collaborators: Beijing Cancer Hospital; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Chinese PLA General Hospital; Fudan University; Guizhou Cancer Hospital (The Affiliated Cancer Hospital of Guizhou Medical University); Henan Cancer Hospital; Jiangsu Cancer Institute & Hospital; Jilin Provincial Tumor Hospital; Peking University Third Hospital; Shandong Cancer Hospital; Sichuan Cancer Hospital and Research Institute; Sun Yat-sen University; Xiangya Hospital of Central South University; Xijing Hospital Attached Air Force Medical University; Zhejiang Cancer Hospital